UMP Healthcare Holdings Limited
0722.HK · Hong Kong Stock Exchange · HKD
0,375HKD
0,00 (0,00 %)Stand 6. Nov., 7:59
Kennzahlen
- Eröffnung
- 0,375
- Vortag
- 0,375
- Tagesspanne
- 0,375 – 0,375
- 52 Wochen
- 0,315 – 0,50
- Volumen
- 10.000
- Ø Volumen
- 35.391
- Börsenwert
- 304,11 Mio. HKD
- KGV
- -3,9
- Gewinn je Aktie (TTM)
- -0,06
- Dividendenrendite
- 8,8 %
- Beta
- 0,3
- Nächste Zahlen
- –
Finanzen
| HKD | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Umsatz | 716,97 Mio. | 727,36 Mio. | 748,49 Mio. | 727,75 Mio. | 666,2 Mio. |
| Herstellungskosten | 341,95 Mio. | 236,75 Mio. | 56,24 Mio. | 225,06 Mio. | 202,25 Mio. |
| Bruttogewinn | 375,02 Mio. | 490,61 Mio. | 692,25 Mio. | 502,69 Mio. | 463,95 Mio. |
| Forschung und Entwicklung | 0 | 0 | 0 | 0 | 0 |
| Vertrieb und Verwaltung | 445,57 Mio. | 272,38 Mio. | 269,4 Mio. | 269,44 Mio. | 249,11 Mio. |
| Operatives Ergebnis | −70,55 Mio. | 218,23 Mio. | 95,4 Mio. | 66,77 Mio. | 81,75 Mio. |
| EBITDA | 26,97 Mio. | 143,3 Mio. | 161,98 Mio. | 178,21 Mio. | 168,03 Mio. |
| Nettogewinn | −74,64 Mio. | 31,44 Mio. | 40,64 Mio. | 60,45 Mio. | 72,17 Mio. |
| Gewinn je Aktie (verwässert) | -0,09 | 0,04 | 0,05 | 0,08 | 0,07 |
Bewertung
Letzte 12 Monate
- KGV
- -3,9
- Kurs-Umsatz-Verhältnis
- 0,4
- Kurs-Buchwert-Verhältnis
- 0,5
- PEG
- 0,0
- Bruttomarge
- 59,2 %
- Operative Marge
- 1,6 %
- Nettomarge
- −10,4 %
- Verschuldungsgrad
- 0,2
- EV/EBITDA
- 4,2
- Eigenkapitalrendite
- −10,8 %
- Kapitalrendite (ROIC)
- 1,4 %
- Free-Cashflow-Rendite
- 34,4 %
Analysten
Einstufungen
Gerade nicht verfügbar.
Kursziel
Gerade nicht verfügbar.
Quartalszahlen
Gerade nicht verfügbar.
Dividenden und Splits
Gerade nicht verfügbar.
Aktiensplits
Gerade nicht verfügbar.
Eigentümer
Institutionen
Gerade nicht verfügbar.
Insider-Geschäfte
Gerade nicht verfügbar.
Vergleichbare Unternehmen
Gerade nicht verfügbar.
Über das Unternehmen
UMP Healthcare Holdings Limited, an investment firm, delivers a broad spectrum of medical and wellness provisions across Hong Kong, Macau, and mainland China. The company's operations are divided into two main divisions: Corporate Healthcare Solution Services and Clinical Healthcare Services. Its extensive service portfolio encompasses virtual medical support, general family practice, and specialized consultations covering diverse fields like internal medicine, surgery, pediatrics, cardiology, dermatology, ENT, orthopedics, ophthalmology, urology, gastroenterology, endocrinology, and diabetes. Additionally, it provides comprehensive dental services, including implants, cosmetic procedures, periodontal care, and orthodontics, alongside traditional Chinese medicine. The company further extends its offerings to include physiotherapy, addressing muscle strengthening, limb and hand function, and eye-hand coordination. Other key services feature day surgery and endoscopy, advanced diagnostic imaging and laboratory testing, health assessments, visa-required medical examinations, immunization and advisory services, vision correction and optometry, reconstructive and aesthetic surgeries (plastic, head, and neck), dermatological and cosmetic treatments, ongoing chronic disease management, and COVID-19 screening. Furthermore, UMP Healthcare is involved in delivering training and advisory services within the healthcare sector. Its client base includes insurance providers, corporate clients, and individual self-paying patients. Established in 1990, UMP Healthcare Holdings Limited has its main offices situated in Central, Hong Kong.
- CEO
- Cheuk Kwan Kwok
- Mitarbeitende
- 494
- Hauptsitz
- Hong Kong, HK
- Sektor
- Healthcare
- Branche
- Medical - Care Facilities
- Börsengang
- 27. Nov. 2015
- Website
- www2.ump.com.hk
Nachrichten
Gerade nicht verfügbar.
Kurse mindestens 15 Minuten verzögert. Daten: Financial Modeling Prep. Keine Anlageberatung.